Abstract
Pretreatment of peritoneal exudate cells (PEC) for 24 to 48 hr with mouse amniotic fluid (MAF) results in a marked reduction in their ability to present antigen in a macrophage-T cell dependent antigen-induced lymphocyte proliferative assay. Since we showed that MAF did not inhibit the uptake of antigen by the antigen-presenting cells, presumably the site of action is either on "processing," T-macrophage interactions and/or on the secretion of soluble factors by macrophages. Whether suppression is the result of a direct effect on MAF on the antigen-presenting cell or indirectly via another cell type present in the PEC preparations was not established by this study. However, our data suggest that a major (although perhaps not sole) site of action of the suppressive factor(s) in MAF is at the level of the antigen-presenting cell. The biologic relevance of these in vitro observations is discussed in regard to the defects of immune function in fetal and neonatal animals.
Cite
CITATION STYLE
Suzuki, K., & Tomasi, T. B. (1980). Mechanism of immune suppression by murine neonatal fluids. The Journal of Immunology, 125(4), 1806–1810. https://doi.org/10.4049/jimmunol.125.4.1806
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.